From these data, we speculated that IL-11 induction at tumour sites is associated with enhanced expression of arginase-1, VEGF, TGF-β, and IL-10, which may be involved in the suppression of T cell responses in the tumour microenvironment. The gene discussed is VEGFA; the disease is neoplasm.